Published in Gene Therapy Weekly, August 18th, 2005
The development of drug eluting stents has grown rapidly since DES became the standard of care for treating coronary blockages in the U.S. and in Europe. Latest clinical research findings indicate that DES reduce the need for repeat percutaneous transluminal coronary...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.